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Öz
Amaç: Orta ve ciddi ovaryan hiperstimülasyon sendromunda (OHSS) kullanılan perkütan pigtail kateter uygulamasının, intrasitoplazmik sperm 
enjeksiyonu (ICSI) uygulaması sonucu oluşan gebelik sonuçlarına etkisini araştırmayı amaçladık. 
Gereç ve Yöntemler: Retrospektif olan bu çalışma 2006-2014 yılları arasında tersiyer bir in vitro fertilizasyon ünitesinde uygulanan ICSI sonucunda gelişen 
OHSS nedeniyle yatarak tedavi edilen 189 hastayı içermektedir. Bu hastalardan 63 hastaya pigtail kateteri uygulanmış, 126 hastaya uygulamaya gerek 
kalmamıştır. Yüz yetmiş üç hastanın obstetrik sonuçlarına ulaşılabilmiş, bu hastalarda kateter uygulanan ile uygulanmayan arasında obstetrik sonuçlar 
karşılaştırılmıştır.
Bulgular: Pigtail kateter uygulamasına bağlı hiçbir hastada enfeksiyon, vasküler veya intraabdominal organ yaralanması gibi komplikasyonlar izlenmemiştir. 
Pigtail kateter uygulanan ve uygulanmayan hastalarda düşük, erken doğum, gestasyonel diabetes mellitus ve preeklampsi oranlarında fark izlenmemiştir 
(p>0,05). Pigtail kateter uygulanan hasta grubunda ise hastanın OHSS nedeniyle hastaneye ikinci yatış oranı istatistiksel olarak anlamlı olmasa da daha 
düşük izlenmiştir (p=0,08).
Sonuç: ICSI tedavisi nedeniyle gelişen OHSS’de batında distansiyon yaratan asitin direnajında pigtail kateter kullanımı güvenli ve etkindir. Perkütan 
direnaj kateteri olan pigtail kateterinin, uygulanan hasta grubunda uygulanmayanlara göre perinatal sonuçlarında fark izlenmemiştir. Buna ek olarak, OHSS 
semptomlarını azaltması amacıyla uygulanan pigtail kateteri, hastaların aynı şikayetlerle hastaneye mükerrer yatışlarında azalma sağlamıştır.
Anahtar Kelimeler: Ovaryan hiperstimülasyon sendromu, asit, pigtail kateter, in vitro fertilizasyon
Abstract
Objective: To evaluate the effects of percutaneous pigtail catheter drainage on the outcomes of intracytoplasmic sperm injection (ICSI) pregnancies 
following moderate or severe ovarian hyperstimulation syndrome (OHSS).
Materials and Methods: This retrospective study included 189 patients hospitalized for OHSS following ICSI treatment in a tertiary in vitro fertilization 
unit between 2006 and 2014. Pigtail catheters were applied in 63 patients; the other 126 patients did not need that treatment. The obstetric reports of 173 
patients could be accessed and were examined to investigate the pregnancy outcomes of those with and without catheters.
Results: No complications such as infection or vascular or intra-abdominal organ trauma were observed related to the pigtail application. There were no 
differences in abortus, preterm labor, gestational diabetes mellitus, and preeclampsia ratio between the pigtail and control groups (p>0.05). The rate of 
readmission to hospital for OHSS was lower in the pigtail group than in the control group although not statistically significant (p=0.08).
Conclusion: Pigtail application is a safe and effective method for draining ascites in patients with OHSS after ICSI treatment. The use of pigtail catheters had 
no adverse effects on the perinatal outcomes of patients hospitalized with OHSS who became pregnant after ICSI treatment. In addition, the percutaneous 
drainage of ascites via a pigtail catheter helped prevent the readmission of patients with moderate or severe OHSS.
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Introduction
Ovarian hyperstimulation syndrome (OHSS) is a serious and 
sometimes life-threatening complication of in vitro fertilization 
(IVF) treatment. Although various preventive measures 
are taken, the incidence of OHSS is still around 2%(1), and 
management plays an important role in this potentially lethal 
complication. There are no OHSS-free clinics, although there 
are preventive measures such as freeze-all protocols and lower 
ovarian stimulation IVF protocols.
Mild-to-severe forms of clinical findings such as leukocytosis, 
hemoconcentration, hypovolemia, edema, ascites, hydrothorax, 
pericardial effusion, thromboembolic events, oligo or anuria, 
acute respiratory distress syndrome, and multiple organ failure 
can be seen due to extravasation of intravascular protein-rich 
fluid to the third spaces. Ascites form as a result of the underlying 
pathophysiology and aggravate the course of the disease. In the 
management of OHSS, it is necessary to eliminate the ascites to 
alleviate symptoms, which include abdominal discomfort and 
dyspnea. Abdominal paracentesis may need to be performed 
several times, and it is usually done blindly. An easier and safer 
method of draining ascites is to use a pigtail catheter, which is 
inserted easily into the abdomen percutaneously under local 
anesthesia and guided using ultrasonography(2). Pigtail catheters 
have proven to be safe for draining ascites fluid. However, 
it is not clear whether this invasive procedure creates any 
procedure-related risk for pregnant patients such as bleeding, 
infection, trauma to neighbouring intraabdominal organs or 
preterm delivery.
To the best of our knowledge, there are no data comparing 
the obstetric outcomes of patients with pigtail catheters and 
controls. In our study, therefore, we evaluated the obstetric 
outcomes of patients who experienced an IVF/intracytoplasmic 
sperm injection (IVF/ICSI) pregnancy following OHSS, and 
compared patients with and without pigtail catheters.
Materials and Methods
Patient population
Between May 2006 and September 2014, a total of 9289 
consecutive IVF/ICSI cycles were performed at our University 
Hospital, Department of Obstetrics and Gynecology, Division of 
Reproductive Endocrinology and IVF Unit. One hundred and 
eighty-nine number of patients who were hospitalized due to 
moderate or severe OHSS with ascites were included in the study. 
Those whose obstetric data could not be obtained were excluded. 
We could be able to access the obstetric outcomes of 173 number 
of patients treated with or without pigtail catheters in two separate 
groups. Abortus ratios, preterm labor ratios, preterm premature 
rupture of membrane (PPROM) ratios, and other pregnancy 
outcomes such as preeclampsia, intrauterine growth retardation 
(IUGR), gestational diabetes mellitus (GDM), and birth weights 
and birth weeks of gestations were analyzed between the two 
groups. The study was approved by the ethics committee of 
the university. This is a retrospective study; therefore, informed 
consent was not required from the patients.
Ovarian hyperstimulation syndrome treatment and follow-up
The classification of OHSS was defined according to the 
criteria of Golan et al.(3) and Navot et al.(4). Moderate OHSS 
was defined as abdominal distention and discomfort, nausea, 
vomiting, diarrhea, enlarged ovaries 5-12 cm in diameter, 
and presence of ascites. Severe OHSS was defined as massive 
ascites, hydrothorax, breathing difficulties, hematocrit >45%, 
leukocytes >15.000, creatinine clearance ≤50 mL/min, oliguria, 
and liver dysfunction.
In our clinic, hospitalization is recommended for patients 
with moderate and severe OHSS to facilitate close monitoring. 
During follow-up, patients with OHSS are treated with bed 
rest, and the following measurements are taken every day: body 
weight, waist circumference, vital signs every four hours, urine 
output, and intravenous or oral fluid intake. Total daily fluid 
intake is limited to 3000 mL/day. If the patient cannot tolerate 
oral fluid intake, parenteral replacement is administered. 
Hydroxyethyl starch (HES) solution (6% HES 130/0.4 in 0.9% 
sodium chloride injection; Voluven®, Germany) is added to 
the parenteral solution to inhibit the shifting of intravenous 
fluid to the extracellular plain. If abdominal distention and 
discomfort are too high and oliguria is present, a pigtail 
catheter (8-0 French Flexima Drainage Catheter®; Boston 
Scientific, USA) is applied. During follow-up, if the ascites 
does not regress, a human albumin (human albumin 20%, 100 
mL; Octapharma, Austria) infusion is given to patients who 
have decreased serum albumin levels. To prevent deep venous 
thrombosis, it is suggested that patients wear venous support 
stockings, and low-molecular-weight heparin (5000 units per 
day) is ordered. When morning hematocrit levels are ≤38% 
or the patients’ symptoms are alleviated, discharge from the 
hospital is recommended.
The following patient data were recorded: age; infertility 
duration; IVF indication; IVF protocol; total gonadotropin doses 
used in IVF; estradiol level on human chorionic gonadotropin 
(hCG) day; number of follicles collected on oocyte pickup 
(OPU) day; total HES or albumin solution infused during 
treatment; hematocrit, leukocyte, platelet, and electrolyte 
counts on the days of admission to and discharge from hospital; 
length of stay in hospital; readmission to hospital, if necessary; 
clinical pregnancy and live birth rate; singleton, twin, or triplet 
pregnancy; and infant birth weight.
During the obstetric follow-up, the following tests were 
administered to diagnosis GDM. First, a 50-g oral glucose 
challenge test was performed between 24-28 weeks of gestation; if 
the first-hour glucose level was >140 mg/dL, a 100-g oral glucose 
tolerance test (OGTT) was performed. In the case of familial 
PRECIS: Pigtail application is a safe and effective in draining ascites in patients with ovarian hyperstimulation syndrome after 
intracytoplasmic sperm injection treatment and had no adverse effects on perinatal outcomes.
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history of diabetes mellitus or history of GDM during previous 
pregnancy, OGTT is suggested just after the first visit. Fasting, 
first-, second-, and third-hour glucose values greater than 95, 
180, 155, and 140 mg/dL, respectively, were diagnosed as GDM. 
Preeclampsia was defined as blood pressure ≥140/90 mmHg 
measured at two different times and ≥300 mg proteinuria in 24-
hour collected urine. Preterm labor was defined as the beginning 
of uterine contractions prior to 37 weeks’ gestation. PPROM 
was defined as rupture of the amniotic membrane prior to 37 
weeks’ gestation. Intrauterine growth restriction was defined as 
weight below the tenth percentile for gestational age, which was 
measured sonographically. Miscarriage was categorized as either 
early (before 12 weeks’ gestation), or late (after the 12th week). A 
chemical abortus was diagnosed in the presence of elevated hCG 
level in the patient’s serum without demonstrating a gestational 
sac in the transvaginal sonographic examination.
Statistical Analysis
In the statistical analyses, demographic data of the patients are 
given as observational values, percentage rates, mean values, and 
standard deviation values. The chi-square test was used in the 
correlation analysis of categorical data while comparing the groups, 
and the Mann-Whitney U test was used in the paired comparison 
of continuous data, which generally did not comply with normal 
distribution. In addition, observation numbers obtained on the 
basis of catheter status were compared by applying the method of 
comparison of two rates. The data were analyzed using SPSS for 
Windows version 18.0 (SPSS, Inc., USA).
Results
Between 2006 and 2014, 9289 patients underwent IVF/ICSI 
procedures at the University Hospital, Department of Obstetrics 
and Gynecology, Division of Reproductive Endocrinology and 
IVF Unit. Of those patients, 189 (2%) were hospitalized due to 
severe or moderate OHSS. 
Of the 189 patients hospitalized due to OHSS, 33.3% (n=63) 
required a pigtail catheter and 66.6% (n=126) did not need 
catheterization for abdominal ascites drainage. We found 
no differences between the two groups in terms of age; total 
gonadotropin dose given during IVF treatment; estradiol blood 
level on the day of hCG; oocyte number after OPU; duration of 
infertility; or hemoglobin, hematocrit, and platelet levels on the 
first and last days of hospitalization. With the exception of the 
last day, the catheterized patients had higher platelet levels. In 
addition, the length of hospitalization was longer (p<0.01) and 
the HES and human albumin solution levels used were higher 
(p<0.01) in the catheterized group (Table 1). The duration of 
Table 1. Characteristics of the two groups
Non-catheter group 
(n=126)
Catheter group
(n=63)
p
Age (years) 29.8±4.6 29.3±4.2 0.47
Total dose of gonadotropins used in IVF (mIU/mL) 1731±709 1835±791 0.44
Estradiol levels on day of hCG (pg/mL) 2933±1535 3250±2209 0.33
Oocyte count obtained after OPU process (n) 21±9 22±10 0.53
Infertility duration (year) 6.3±4.3 6.7±4.2 0.55
Hb count on first day of hospitalization (g/dL) 14.3±1.8 14.7±1.5 0.12
Hct ratio on first day of hospitalization (%) 42.5±5.5 43.7±4.6 0.14
PLT count on first day of hospitalization (106/mL) 342±81 368±94 0.05
Hb count on last day of hospitalization (g/dL) 11.7±1 12±1 0.32
Hct ratio on last day of hospitalization (%) 34.9±2.7 35±3 0.06
PLT count on last day of hospitalization (106/mL) 277±66 326±79 <0.01
Length of hospitalization (days)ª 3.1±1.9 7.7±3.6 <0.01
Total HES solution (500 mL)ª 1.34±1.4 3.7±3.7 <0.01
Total human albumin (100 mL)ª 0.07±0.5 0.81±1.8 <0.01
Early OHSS rate (%)β 83.5 55.3 0.01
Late OHSS rate (%)β 16.5 44.7 0.01
Second admission (%)β 17.5 7.9 0.08
Values are mean ± standard deviation
ªNon-parametric tests were used
βChi-square tests were used, for all others, student’s t-test was used
n: Number of patients, IVF: In vitro fertilization, hCG: Human chorionic gonadotropin, OPU: Oocyte pickup, Hb: Hemoglobin, Hct: Hematocrit, PLT: Platelet, HES: Hydroxyethyl starch, 
OHSS: Ovarian hyperstimulation syndrome
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catheterization was 1-9 days in the catheterized group (mean: 
2.9±1.7 days). After being discharged from hospital, 27 (14.3%) 
patients needed to be readmitted to hospital due to OHSS. In 
the catheterized group, the readmission ratio was 7.9%, whereas 
in the non-catheterized group, the readmission ratio was 17.5% 
(p=0.08) (Table 1).
The ratios of singleton, twin, and triplet pregnancies in the two 
groups were statistically similar, but the twin pregnancy ratio 
was higher in the catheterized group (Table 2). The miscarriage 
ratios, whether early miscarriage or chemical abortus, were 
statistically similar between the two groups (p>0.05) (Table 2).
The clinical pregnancy ratio of the catheterized group was 
higher than that of the non-catheterized group (p<0.01). In 
addition, the catheterized group had a statistically higher live 
birth ratio (p=0.04) (Table 2). The early OHSS ratio was higher 
in the non-catheterized group, and the late OHSS ratio was 
higher in the catheterized group (p=0.01). 
The perinatal outcomes of the two groups, such as preterm 
labor, GDM, preeclampsia, PPROM, IUGR, and miscarriage 
ratios, were similar (Table 2). 
The birth weights and gestational ages of the twin and 
singleton pregnancies were compared. The mean birth weight 
and gestational age at delivery of twins in the catheterized 
group were 2085 g and 34.6 weeks, respectively; in the non-
catheterized group, these values were 2200 g and 35 weeks, 
respectively (p=0.65). The mean birth weight and gestational 
age at delivery of singleton babies in the catheterized group were 
3251 g and 37.6 weeks, respectively; in the non-catheterized 
group, these values were 2728 g and 36.6 weeks, respectively 
(p=0.08) (Table 2).
Regression analyses of live birth rates of the two groups were 
performed, the catheter presence and other factors did not 
affect the live birth rates of the two groups (p>0.05) (Table 3).
Discussion
In our study, we compared the complications and obstetric 
outcomes of patients who had pigtail catheters applied for 
ascites drainage with those of patients who did not require 
catheterization. Pigtail catheter application, although 
conducted under the guidance of ultrasonography, is still an 
invasive method. During the procedure, the abdominal wall is 
punctured, which can cause peritoneal irritation or secondary 
infections related to the process itself, possibly resulting in fetal 
or maternal complications. We encountered no complications 
related to pigtail catheter application, such as infection, or 
bowel or other intra-abdominal organ trauma. We know that 
Table 2. Obstetric outcomes of the two groups
Non-catheter group Catheter group p
Ratio of pregnancy (n) (%) 71 (62.8) 56 (91.8) <0.01
Ratio of abortus (n) (%) 15 (13.2) 16 (26.2) 0.09
     Chemical pregnancy 2 (2.8) 3 (5.3) 0.17
     Miscarriage 13 (18.3) 13 (23.2) 0.18
Ratio of live birth (n) (%) 56 (49.5) 40 (65.5) 0.04
     Singleton pregnancy 40 (56.3) 25 (44.6) 0.20
     Twin pregnancy 15 (21.1)  14 (25) 0.50
     Triplet pregnancy 1 (1.4)  1 (1.7) 1.00
Ratio of preterm labor (n) (%) 13 (18.3) 10 (17.8) 0.80
     Singleton pregnancy 8 (11.2) 4 (7.1) 0.70
     Twin pregnancy 4 (5.6) 5 (8.9) 0.57
     Triplet pregnancy 1 (1.4) 1 (1.7) 1.00
GDM (n) (%) 6 (8.4) 1 (1.7) 0.23
Preeclampsia (n) (%) 3 (4.2) 2 (3.5) 1.00
Twin birth weight (g ± SD)ª 2200±347 2085±544 0.65
Twin gestational age at delivery (wk ± SD)t 35±1 34.6±2 0.64
Singleton birth weight (g ± SD)t 2728±735 3251±281 0.08
Singleton gestational age at delivery (wk ± SD)t 36.6±2.7 37.6±0.6 0.32
ªNon-parametric tests were used
tStudent’s t-test, all other tests were chi-square tests
n: Number of patients, GDM: Gestational diabetes mellitus, g: Grams, SD: Standard deviation, wk: Weeks
98
Turk J Obstet Gynecol 2017;14:94-9 Çağlar Aytaç et al. Pigtail catheter application in hyperstimulated in vitro fertilization pregnancies
the inflammatory process can cause the release of cytokines and 
chemokines that can precipitate preterm labor(5). 
Obstetric outcomes such as preterm labor, early and late 
miscarriages, preeclampsia, GDM, PPROM, IUGR, and fetal 
anomaly were compared between the two groups, and we found 
no differences. The analysis of miscarriage rates, including the 
subgroups early, late, and chemical miscarriage, also revealed 
similarities between the two groups (Table 2). Overall, the 
miscarriage ratio of the patients who had ascites drainage with 
pigtail catheter was 26.2%. The miscarriage ratio which was 
13.2% in the control group was lower than the catheter group, 
but the difference was not statistically significant. The higher 
ratios of miscarriage could be explained by higher rates of OHSS 
ratios in the catheterized group than in the control group. Most 
of the patients who were hyperstimulated had polycystic ovaries 
and the miscarriage rate after IVF treatment is higher in patients 
with polycystic ovary syndrome (PCOS)(6,7). In our groups, the 
numbers of patients with PCOS were similar; the higher ratios 
of miscarriage was not higher than the miscarriages rates of 
other studies such as Chen et al.(8) (26.6%), Serdyńska-Szuster 
et al.(9) (26.9%), and Raziel et al.(1) (38%). 
Multiple pregnancy is a risk factor for preterm labor; however, 
although not statistically significant (p=0.06), the rate of twin 
pregnancy was higher in the pigtail group. The preterm labor 
ratios did not differ between the groups (p=0.28). In the 
literature, the preterm labor rate in patients with OHSS after 
IVF treatment varies from 1% to 28%(10-12). In the study by Haas 
et al.(13), pregnancy outcomes in patients with severe OHSS 
following ascetic drainage were evaluated, and their preterm 
labor risk was found as 12.5%. In our study group, the preterm 
labor risk was 18.5%, and that of the control group was 19% 
(p>0.05). However, the Haas et al.(13) study included a small 
case sample (n=16), they had no control group, and most 
importantly, the pregnancies were all singletons. Even though 
twins and triplets were included in our study, the overall 
preterm labor rate was not much higher than that of the Haas 
et al.(13) study. 
In our study, there were no differences between the groups in 
terms of birth weight or gestation age at delivery. The results 
regarding pregnancy outcomes after OHSS in IVF treatment 
revealed no differences between the groups and they were 
better than those in the review of Raziel et al.(14).
The rates of risk factors for developing OHSS, such as age, diagnosis 
of PCOS, total dose of gonadotropins during controlled ovarian 
hyperstimulation, estradiol level on the day of hCG, and oocyte 
numbers, were similar between the two groups. However, the 
catheterized group had a longer duration of hospitalization, they 
required greater amounts of HES and human albumin solution, 
and their platelet levels were higher on the day of discharge from 
hospital. These results were not entirely unexpected, because 
Table 3. Logistic regression of factors effecting live birth rates
p Odds ratio 95% Confidence interval
Lower Upper
 Age 0.80 1.022 0.859 1.215
Total dose of gonadotropins used in IVF 0.38 1.000 1.000 1.001
Estradiol levels on day of hCG 0.64 1.000 1.000 1.000
Oocyte count obtained after OPU process 0.43 0.956 0.853 1.071
Oocyte count obtained after OPU process 0.52 1.045 0.912 1.198
Infertility duration 0.17 0.896 0.764 1.050
Hb count on first day of hospitalization 0.39 0.592 0.177 1.978
Hct ratio on first day of hospitalization 0.44 1.180 0.773 1.802
PLT count on first day of hospitalization 0.87 0.999 0.987 1.011
Hb count on last day of hospitalization 0.05 3.372 1.002 11.348
Hct ratio on last day of hospitalization 0.05 0.648 0.414 1.014
PLT count on last day of hospitalization 0.74 1.002 0.989 1.015
Length of hospitalization 0.06 1.434 0.972 2.115
Total HES solutiona 0.08 0.759 0.556 1.037
Total human albumina 0.33 0.766 0.446 1.314
Catheterª 0.68 1.357 0.307 5.997
ªCategorical value
IVF: In vitro fertilization, hCG: Human chorionic gonadotropin, OPU: Oocyte pickup, Hb: Hemoglobin, Hct: Hematocrit, PLT: Platelet,  
HES: Hydroxyethyl starch
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the ascites in the catheterized group were more severe, thus 
requiring the pigtail catheter. Although the pigtail group had a 
more severe form of OHSS, the mean duration of hospitalization, 
i.e. the recovery time from OHSS was 7.7 days; however, in the 
study of Nouri et al.(15), the recovery time from OHSS was 9 days. 
Even if the pigtail group had a longer hospitalization time than 
the control group, it was still lower than the cases in the study of 
Nouri et al.(15). Application of a pigtail catheter may not increase 
the length of hospitalization, but the severity of ascites might slow 
the recovery process. 
Then clinical pregnancy ratio, live birth ratio per cycle, and 
late OHSS ratios were higher in the pigtail group than in the 
control group (p<0.05) (Table 2). When we analyzed the 
regression analysis of factors that effected the live birth rate, we 
found no significance between them (Table 3). The higher late 
OHSS ratios in the pigtail group can be reasonably explained 
by the higher pregnancy rate. In addition, it is known that the 
pregnancy rate is higher among patients undergoing IVF/ICSI 
who had OHSS(1). Although not statistically significant, the 
catheterized group had a lower rate of hospital readmission 
than the non-catheterized group, despite the fact that the 
catheters were used in patients who were more clinically severe. 
This finding suggests that in managing OHSS, use of the pigtail 
catheter has an advantage in that it can help decrease hospital 
readmission rates.
Study Limitations
The major limitation of our study is its retrospective nature. 
Pigtail application is an invasive procedure, as such we did 
not have the chance to randomize the patients who had 
severe OHSS. Abdominal paracentesis may be an alternative 
to the pigtail catheter, but abdominal paracentesis needs to be 
applied blindly everyday through the abdominal wall. Pigtail 
application for drainage of ascites is made only once, thus 
the single application may be an advantage over repetitive 
abdominal paracentesis, which has not been practiced in our 
clinic for many years. 
Conclusion
The application of pigtail catheters did not decrease the 
pregnancy ratio or live birth ratio in patients with OHSS. 
In addition, the hospital readmission rate was lower. The 
obstetric outcomes were similar between both groups. Thus, 
percutaneous pigtail catheters can be used in the treatment 
of ascites in patients with OHSS without raising concerns 
regarding pregnancy outcomes.
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